Challenges of Empirical Antibiotic Therapy for Community-Acquired Pneumonia in Children

BACKGROUND: Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality globally, responsible for more than 14% of deaths in children younger than 5 years of age. Due to difficulties with pathogen identification and diagnostics of CAP in children, targeted antimicrobial therapy...

Descripción completa

Detalles Bibliográficos
Autor principal: Rodrigues, Charlene M.C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522971/
https://www.ncbi.nlm.nih.gov/pubmed/28761583
http://dx.doi.org/10.1016/j.curtheres.2017.01.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522971/
https://www.ncbi.nlm.nih.gov/pubmed/28761583
http://dx.doi.org/10.1016/j.curtheres.2017.01.002

Ejemplares similares